Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 1/2
    1
    25%
    Phase 4
    2
    50%
    Not Applicable
    1
    25%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    2

    Late Stage

    Phase Distribution4 total trials
    Phase 1/2Combined phases
    1(25.0%)
    Phase 4Post-market surveillance
    2(50.0%)
    N/ANon-phased studies
    1(25.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Completed(2)
    Other(2)

    Detailed Status

    Completed2
    unknown2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 1/21 (25.0%)
    Phase 42 (50.0%)
    N/A1 (25.0%)

    Trials by Status

    completed250%
    unknown250%

    Recent Activity

    0 active trials
    Showing 4 of 4
    completedphase_4

    The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children

    NCT00137553
    unknownnot_applicable

    IPTp Plus ITNs for Malaria Control in Pregnant Women

    NCT00209781
    unknownphase_1_2

    IPTi in Mozambican Infants for Malaria Prevention

    NCT00209794
    completedphase_4

    Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia

    NCT00270530

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT00137553Phase 4

    The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children

    Completed
    NCT00209781Not Applicable

    IPTp Plus ITNs for Malaria Control in Pregnant Women

    Unknown
    NCT00209794Phase 1/2

    IPTi in Mozambican Infants for Malaria Prevention

    Unknown
    NCT00270530Phase 4

    Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia

    Completed

    All 4 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    4